- Time
- Topic
- Speaker
- Moderator
- 16:00 - 16:40
-
Advances in Deep Brain Stimulation for Parkinson’s Disease: Mechanisms and Innovations
- Speaker:
Abdelhamid Benazzouz
- Moderator:
Chun-Hwei Tai
- Chun-Hwei Tai
- MD, PhD
-
Clinical Associate Professor, National Taiwan University Hospital, National Taiwan University
Attending Physician, Center for Parkinson and movement disorders and Department of Neurology
E-mail:chtai1502@ntu.edu.tw
Executive Summary:
Dr. Chun-Hwei Tai serves as an attending physician in the Department of Neurology at NTUH since 2000.He is a neurologist with special interests in the surgical treatment of Parkinson’s disease (PD) and other movement disorders. Dr. Tai received his training on deep brain stimulation (DBS) in both NTUH and University Hospital Center (CHU) of Joseph Fourrier University, at Grenoble, France (Professor Alim-Louis Benabid). Dr. Tai also engages in basic basal ganglia researches in INSERM U318 / CNRS U5543 in France (Dr. Abedelhamid Benazzouz and Dr. Erwan Bezard) and in Taiwan (Dr. Chung-Chin Kuo). Dr. Tai developed the movement disorder surgical program with Dr. Sheng-Hong Tseng and Dr. Ruey-Meei Wu, in the Center for Parkinson and Movement disorders in NTUH. Dr. Tai is currently the clinical associate professor in neurology at National Taiwan University and also a Council member of Taiwan Movement Disorder Society
- Time
- Topic
- Speaker
- Moderator
- 16:40 - 17:20
-
Precision Medicine for Parkinson’s Disease
- Speaker:
Chin-Hsien Lin
- Moderator:
Tu-Hsueh Yeh
- Tu-Hsueh Yeh
- MD, PhD
-
Vice Superintendent, Taipei Neuroscience Institute
President, Taiwan Movement Disorder Society
Director of Medical Education, Taipei Medical University Hospital
E-mail:neuroyeh@gmail.com
Executive Summary:
Dr. Tu-Hsueh Yeh is a distinguished neurologist, clinician-scientist, and academic leader with expertise in Parkinson’s disease (PD) and movement disorders, neurogenetics, and translational neuroscience. He received his M.D. from Taipei Medical University and completed his neurology training at Chang Gung Memorial Hospital (CGMH). He subsequently earned his Ph.D. in Clinical Medical Sciences from Chang Gung University, where his research focused on glutamatergic neurotransmission and neurophysiology. From 2006 to 2008, he pursued postdoctoral and clinical research training at Washington University in St. Louis under Professor David H. Gutmann, investigating NF1-related neural development, tumorigenesis, and genetic biomarkers.
Building on this foundation, Dr. Yeh previously established a neurogenetics laboratory at CGMH. His major research focus on elucidating the genetic and molecular mechanisms underlying PD and other movement disorders, developing experimental disease models, identifying biomarkers and genetic modifiers of disease phenotypes, and investigating mechanisms of neuroprotection. His translational research aims to bridge genetic discoveries and molecular pathways with clinically meaningful biomarkers, patient stratification, and precision therapeutic strategies.
Dr. Yeh has held numerous academic and institutional leadership positions and currently serves as Director of Medical Education at Taipei Medical University Hospital. He is President of the Taiwan Movement Disorder Society and has held leadership roles in the Taiwan Neurological Society and Taiwan Headache Society.
Beyond academic medicine, Dr. Yeh has demonstrated a strong commitment to global health. He let the Health Care Improvement Project of Taiwan Medical Mission in the Kingdom of Eswatini, advancing postgraduate medical education, healthcare capacity building, and sustainable international medical collaboration.